{"id":6000,"date":"2026-11-11T15:30:57","date_gmt":"2026-11-11T14:30:57","guid":{"rendered":"https:\/\/idldiagnostics.com\/?p=6000"},"modified":"2026-11-11T15:31:18","modified_gmt":"2026-11-11T14:31:18","slug":"concile-global-explores-opportunities-to-expand-its-poct-portfolio","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/","title":{"rendered":"Concile Global unders\u00f6ker m\u00f6jligheter att ut\u00f6ka sin POCT-portf\u00f6lj"},"content":{"rendered":"<p>Under ett nyligen bes\u00f6k p\u00e5 KSB Biotech i Kina unders\u00f6kte IDL Diagnostics och dess tyska partnerm\u00f6te m\u00f6jligheterna att komplettera Concile Globals internationella portf\u00f6lj av testl\u00f6sningar f\u00f6r anv\u00e4ndning p\u00e5 plats.<\/p>\n<p>Diskussionerna inriktades p\u00e5 biomark\u00f6rer som \u00e4r kompatibla med de l\u00e4splattformar som redan anv\u00e4nds f\u00f6r UBC\u00ae Rapid, vilket potentiellt skulle kunna m\u00f6jligg\u00f6ra ett bredare utbud genom delade instrument och distributionskanaler. M\u00f6jligheterna utv\u00e4rderas fortfarande.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global\u2019s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already used for UBC\u00ae Rapid, potentially enabling a broader offering through shared instruments and distribution channels. Opportunities remain under evaluation. [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":6001,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11],"tags":[],"dipi_cpt_category":[],"class_list":["post-6000","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global\u2019s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already used for UBC\u00ae Rapid, potentially enabling a broader offering through shared instruments and distribution channels. Opportunities remain under evaluation. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T14:30:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-11T14:31:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Erika\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Erika\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/\"},\"author\":{\"name\":\"Erika\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/9d5c90e500be2815ad1ec1b7ea4ebe2b\"},\"headline\":\"Concile Global explores opportunities to expand its POCT portfolio\",\"datePublished\":\"2026-11-11T14:30:57+00:00\",\"dateModified\":\"2026-11-11T14:31:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/\"},\"wordCount\":66,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/KSB-Oct.2026.jpeg\",\"articleSection\":[\"News\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/\",\"name\":\"Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/KSB-Oct.2026.jpeg\",\"datePublished\":\"2026-11-11T14:30:57+00:00\",\"dateModified\":\"2026-11-11T14:31:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/KSB-Oct.2026.jpeg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/KSB-Oct.2026.jpeg\",\"width\":1707,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2026\\\/11\\\/11\\\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Concile Global explores opportunities to expand its POCT portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/9d5c90e500be2815ad1ec1b7ea4ebe2b\",\"name\":\"Erika\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g\",\"caption\":\"Erika\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/erika\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/","og_locale":"sv_SE","og_type":"article","og_title":"Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics","og_description":"During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global\u2019s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already used for UBC\u00ae Rapid, potentially enabling a broader offering through shared instruments and distribution channels. Opportunities remain under evaluation. [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/se\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2026-11-11T14:30:57+00:00","article_modified_time":"2026-11-11T14:31:18+00:00","og_image":[{"width":1707,"height":1280,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg","type":"image\/jpeg"}],"author":"Erika","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Erika","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/"},"author":{"name":"Erika","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/9d5c90e500be2815ad1ec1b7ea4ebe2b"},"headline":"Concile Global explores opportunities to expand its POCT portfolio","datePublished":"2026-11-11T14:30:57+00:00","dateModified":"2026-11-11T14:31:18+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/"},"wordCount":66,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg","articleSection":["News"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/","url":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/","name":"Concile Global explores opportunities to expand its POCT portfolio - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg","datePublished":"2026-11-11T14:30:57+00:00","dateModified":"2026-11-11T14:31:18+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/11\/KSB-Oct.2026.jpeg","width":1707,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2026\/11\/11\/concile-global-explores-opportunities-to-expand-its-poct-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"Concile Global explores opportunities to expand its POCT portfolio"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/9d5c90e500be2815ad1ec1b7ea4ebe2b","name":"Erika","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/879931d999542553c2fb61b3efe17067c9c9d1bebc74458e8f52713fcc4ddfe3?s=96&d=mm&r=g","caption":"Erika"},"url":"https:\/\/idldiagnostics.com\/se\/author\/erika\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/6000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=6000"}],"version-history":[{"count":1,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/6000\/revisions"}],"predecessor-version":[{"id":6002,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/6000\/revisions\/6002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/6001"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=6000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=6000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=6000"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=6000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}